EnsoData

EnsoData is an AI-powered platform built for modern sleep medicine. It offers a complete ecosystem of FDA-cleared tools that cover the entire patient journey — from diagnosing sleep apnea at home to monitoring long-term therapy. The core products include EnsoHST, a multi-night home sleep test with a wearable device; EnsoSleep, which uses AI to automatically score and analyze sleep studies; EnsoHub, a central platform to review and manage all scored studies; and Therapy Track, which extends the care pathway into ongoing treatment monitoring. Clinics use EnsoData to increase diagnostic volume, eliminate backlogs, and free up sleep technologists to focus on patient care.

What makes EnsoData stand out is its clinical validation and FDA clearance across multiple products. The AI for sleep scoring has been trained on a database of over 3.8 million sleep studies, and it delivers clinically superior results — for example, greater than 92% sensitivity for sleep apnea detection and a 97% patient success rate with the home test. The platform is designed to be simple for patients (a comfortable wearable for multi-night use at home) and efficient for clinicians (a single dashboard to view, edit, and export reports). EnsoData integrates directly into existing clinic workflows, reducing internal complexity while expanding access to sleep diagnostics.

The primary users are sleep clinics, physicians, and registered polysomnographic technologists (RPSGTs). For a clinic, EnsoData means being able to screen more patients for sleep apnea, score studies faster, and monitor therapy remotely — all from one partner. The real-world impact is reaching the millions of undiagnosed sleep apnea patients by making testing more accessible and less burdensome. It's a practical, data-driven approach to a widespread health problem, not a flashy AI demo.